Fibrin gel for controlled release of PDGF and uses thereof
US8377864B2 · kind B2 · utility
3Cited by
12References
35Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 19, 2008 |
| Grant date | Feb 19, 2013 |
| Priority date | — |
| Expiry date | Dec 7, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/414
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in general, to fibrin sealants, which contain platelet derived growth factor (PDGF) for controlled release in situ for therapeutic applications, including musculoskeletal disorders, soft tissue disorders and vascular diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.